Quick Answer
Travere Therapeutics, Inc. reported Common Stock Shares Outstanding of 90.92 million shares for the year ending 2025.
- Travere Therapeutics, Inc. showed an increase of +4.0% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Travere Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on February 19, 2026.
- XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2012: 106,695 shares | Q4 2012: 106,695 shares | Q1 2013: 12.19 million shares | Q2 2013: 12.32 million shares | Q3 2013: 18.38 million shares | Q1 2014: 24.42 million shares | Q2 2014: 26.30 million shares | Q3 2014: 26.32 million shares | Q1 2015: 34.85 million shares | Q2 2015: 35.07 million shares | Q3 2015: 36.01 million shares | Q1 2016: 36.59 million shares | Q2 2016: 36.73 million shares | Q3 2016: 37.70 million shares | Q1 2017: 38.16 million shares | Q2 2017: 38.29 million shares | Q3 2017: 39.28 million shares | Q1 2018: 39.87 million shares | Q2 2018: 40.37 million shares | Q3 2018: 41.17 million shares | Q1 2019: 41.44 million shares | Q2 2019: 42.90 million shares | Q3 2019: 42.96 million shares | Q1 2020: 43.15 million shares | Q2 2020: 50.90 million shares | Q3 2020: 51.02 million shares | Q1 2021: 60.44 million shares | Q2 2021: 60.71 million shares | Q3 2021: 61.02 million shares | Q1 2022: 63.51 million shares | Q2 2022: 63.84 million shares | Q3 2022: 64.15 million shares | Q1 2023: 74.59 million shares | Q2 2023: 74.97 million shares | Q3 2023: 75.11 million shares | Q1 2024: 76.11 million shares | Q2 2024: 76.46 million shares | Q3 2024: 77.91 million shares | Q1 2025: 88.79 million shares | Q2 2025: 89.10 million shares | Q3 2025: 89.46 million shares.
- Over the full 15 years of available data (2011 to 2025), Travere Therapeutics, Inc.'s Common Stock Shares Outstanding has grown by 2,149.3%.
- Historical annual values: Fiscal year 2025: 90.92 million shares | Fiscal year 2024: 87.45 million shares | Fiscal year 2023: 75.37 million shares | Fiscal year 2022: 64.29 million shares | Fiscal year 2021: 62.49 million shares | Fiscal year 2020: 52.25 million shares | Fiscal year 2019: 43.09 million shares | Fiscal year 2018: 41.39 million shares | Fiscal year 2017: 39.37 million shares | Fiscal year 2016: 37.91 million shares | Fiscal year 2015: 36.47 million shares | Fiscal year 2014: 26.05 million shares | Fiscal year 2013: 18.42 million shares | Fiscal year 2012: 8.95 million shares | Fiscal year 2011: 4.04 million shares.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: